These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 15338857)
1. Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate. Guo Y; Fung HB Pharmacotherapy; 2004 Aug; 24(8):1089-94. PubMed ID: 15338857 [TBL] [Abstract][Full Text] [Related]
2. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. Murphy MD; O'Hearn M; Chou S Clin Infect Dis; 2003 Apr; 36(8):1082-5. PubMed ID: 12684925 [TBL] [Abstract][Full Text] [Related]
3. Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection. Antoniou T; Park-Wyllie LY; Tseng AL Pharmacotherapy; 2003 Jan; 23(1):29-43. PubMed ID: 12523458 [TBL] [Abstract][Full Text] [Related]
4. Severe toxicity associated with the combination of tenofovir and didanosine: case report and review. Masiá M; Gutiérrez F; Padilla S; Ramos JM; Pascual J Int J STD AIDS; 2005 Sep; 16(9):646-8. PubMed ID: 16176639 [TBL] [Abstract][Full Text] [Related]
5. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine. Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710 [TBL] [Abstract][Full Text] [Related]
6. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected]. Blanchard JN; Wohlfeiler M; Canas A; King K; Lonergan JT Clin Infect Dis; 2003 Sep; 37(5):e57-62. PubMed ID: 12942419 [TBL] [Abstract][Full Text] [Related]
7. Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients. Hawkins T; Veikley W; Durand-Gasselin L; Babusis D; Reddy YS; Flaherty JF; Ray AS Antimicrob Agents Chemother; 2011 Apr; 55(4):1549-55. PubMed ID: 21282432 [TBL] [Abstract][Full Text] [Related]
8. Effect of tenofovir on didanosine absorption in patients with HIV. Pecora Fulco P; Kirian MA Ann Pharmacother; 2003 Sep; 37(9):1325-8. PubMed ID: 12921517 [TBL] [Abstract][Full Text] [Related]
12. Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy. Butt AA AIDS Read; 2003 Jul; 13(7):344-8. PubMed ID: 12889452 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. Gallant JE; Staszewski S; Pozniak AL; DeJesus E; Suleiman JM; Miller MD; Coakley DF; Lu B; Toole JJ; Cheng AK; JAMA; 2004 Jul; 292(2):191-201. PubMed ID: 15249568 [TBL] [Abstract][Full Text] [Related]
14. Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients. Claas GJ; Jülg B; Goebel FD; Bogner J Eur J Med Res; 2007 Feb; 12(2):54-60. PubMed ID: 17369118 [TBL] [Abstract][Full Text] [Related]
15. Drug points: Fatal lactic acidosis associated with tenofovir. Rivas P; Polo J; de Górgolas M; Fernández-Guerrero ML BMJ; 2003 Sep; 327(7417):711. PubMed ID: 14512477 [No Abstract] [Full Text] [Related]
16. [Fatal lactic acidosis in a patient infected by HIV and treated with stavudine and didanosine]. Mégarbane B; Goldgran-Tolédano D; Guérin JM; Baud F Pathol Biol (Paris); 2000 Jun; 48(5):505-7. PubMed ID: 10949849 [TBL] [Abstract][Full Text] [Related]
17. Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir. Hansen AB; Mathiesen S; Gerstoft J Scand J Infect Dis; 2004; 36(5):389-92. PubMed ID: 15287389 [TBL] [Abstract][Full Text] [Related]
18. Severe lactic acidosis during tenofovir disoproxil fumarate and cobicistat combination for HIV patient. Isoda A; Mihara M; Matsumoto M; Sawamura M BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37923339 [TBL] [Abstract][Full Text] [Related]
19. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients. Taburet AM; Piketty C; Chazallon C; Vincent I; Gérard L; Calvez V; Clavel F; Aboulker JP; Girard PM Antimicrob Agents Chemother; 2004 Jun; 48(6):2091-6. PubMed ID: 15155205 [TBL] [Abstract][Full Text] [Related]